HBO

OxyHeal Health Group, over the past 30 years, has conducted or participated in Hyperbaric and diving research involving animal studies, human studies, and equipment research. Most recently, members of the OxyHeal Health Group have developed, engineered, built and patent-protected the first Hyperbaric incubator, the OxyCure® 3000, in order to conduct genetic research in cellular biology studies. Two of the world’s leading university medical centers are currently conducting studies with the OxyCure® 3000. OxyHeal is fully committed to the support of research to extend the field of Hyperbaric medicine and its uses of high dose oxygen to cure and better treat future and current modalities.



Animal Studies	Human Studies	Genetic & Cellular Studies	Equipment Research
OxyHeal Health Group, over the past 30 years, has conducted or participated in Hyperbaric and diving research involving animal studies, human studies, and equipment research. Most recently, members of the OxyHeal Health Group have developed, engineered, built and patent-protected the first Hyperbaric incubator, the OxyCure® 3000, in order to conduct genetic research in cellular biology studies. Two of the world’s leading university medical centers are currently conducting studies with the OxyCure® 3000. OxyHeal is fully committed to the support of research to extend the field of Hyperbaric medicine and its uses of high dose oxygen to cure and better treat future and current modalities.